Surufatinib in advanced extrapancreatic neuroendocrine tumours (SANET-ep): a randomised, double-blind, placebo-controlled, phase 3 study
Xu, Jianming, Shen, Lin, Zhou, Zhiwei, Li, Jie, Bai, Chunmei, Chi, Yihebali, Li, Zhiping, Xu, Nong, Li, Enxiao, Liu, Tianshu, Bai, Yuxian, Yuan, Ying, Li, Xingya, Wang, Xiuwen, Chen, Jia, Ying, Jieer,Journal:
The Lancet Oncology
DOI:
10.1016/S1470-2045(20)30496-4
Date:
September, 2020
File:
PDF, 1.37 MB
2020